Breaking News

Samsung Introduces Its Latest Radiology Innovations at RSNA 2020

Samsung to highlight its medical imaging portfolio with its latest radiology innovations in ultrasound, digital radiography and mobile computed tomography.

C360 Spine Portfolio Unveiled -NuVasive Advises Launch Represents a Significant Opportunity for Growth As Cervical Spine Procedures Comprise An Approximately $2.6 Bil Segment of the Global Spine Market

"C360 spine portfolio unveiling reflects NuVasive's commitment to deliver innovative technology for the anterior and posterior cervical spine designed to improve the quality of care even in the most established area of spine," said Massimo Calafiore, executive vice president, Global Business Units at NuVasive.

Novel Biosynthetic Tissue Valve 6 Month Clinical Results Reported

Six-month data for 16 patients enrolled across three sites in the United States were presented in a moderated poster session during the American Heart Association Virtual Scientific Sessions from November 13-17, 2020. The poster, P148, is titled, Early Results of a Novel ePTFE-based Pulmonary Valved Conduit in a Pediatric Patient Population.

Retinal-imaging Breakthrough That Can Swiftly Detect Eye Diseases

European researchers are developing a new real-time scanner that will create a full image of a moving eye without any blurring. Teaming up with photonics innovation hub ACTPHAST 4R the scientists at Vrije Universiteit (VU) Amsterdam are progressing their scanner concept to a demonstrator stage to acquire data faster than existing optical imaging technologies.  

Canfield Scientific Acquires Leading German Dermoscopy Company VISIOMED AG

October 8, 2018: Canfield Scientific has announced the acquisition of German company VISIOMED AG – the leading designer and manufacturer of dermoscopy systems.  The resulting business has decades of experience in aesthetic documentation, 3D imaging, clinical photography and reflected light microscopy leading to more choices and services for customers.

“The addition of VISIOMED’s best-in-class optical and digital dermatoscopes are a perfect extension to our imaging portfolio,” stated Doug Canfield, President of Canfield Scientific “Furthermore, their commitment to excellence and organizational culture was a natural fit with our own.”

The acquisition brings a talented management team that will assume leadership roles in the expanded Canfield business.  Dipl.- Ing. (FH) Dirk Holle, previously VISIOMED CEO, will lead Canfield Scientific GmbH, a wholly-owned subsidiary of Canfield Scientific, Inc.  Canfield Scientific GmbH will become a center of excellence for high magnification imaging research and development, as well as a customer support and logistics center for Canfield in Europe.  Peter Klar, previously the VISIOMED global head of sales and marketing, will assume responsibility for commercial sales of Canfield’s imaging systems as Chief Sales Officer (CSO) for Europe.

“Canfield Scientific and VISIOMED’s collaborative synergy allows us to not only grow our product portfolio and research efforts, but also continue expansion of our European footprint,” Klar says. “In this way, we can offer our customers a complete line of medical and aesthetic imaging solutions while still maintaining the highest level of quality that has always been synonymous with both companies.”

The new operation, located in Bielefeld, Germany complements Canfield’s existing clinical services organization in Utrecht Netherlands.  Opened over 10 years ago by Peter Kollias, the Utrecht office will continue to support clinical studies in Europe, Middle East and Africa.

The merged product line, including the full range of VISIOMED dermatoscopes, will be available directly from Canfield Scientific, Inc. in the US and Canfield Scientific GmbH in Germany.  For purchases in other countries, the Canfield and VISIOMED global distribution partner networks will be combined to reflect the integrated product lines. The updated distributor list can be found online at www.canfieldsci.com/distributors.

Latest Posts

INTERCEPT Blood System for Cryoprecipitation Receives FDA Approval States Cerus Corporation

The system is used to produce Pathogen Reduced Cryoprecipitated Fibrinogen Complex for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. 

Samsung Introduces Its Latest Radiology Innovations at RSNA 2020

Samsung to highlight its medical imaging portfolio with its latest radiology innovations in ultrasound, digital radiography and mobile computed tomography.

C360 Spine Portfolio Unveiled -NuVasive Advises Launch Represents a Significant Opportunity for Growth As Cervical Spine Procedures Comprise An Approximately $2.6 Bil Segment of the Global Spine Market

"C360 spine portfolio unveiling reflects NuVasive's commitment to deliver innovative technology for the anterior and posterior cervical spine designed to improve the quality of care even in the most established area of spine," said Massimo Calafiore, executive vice president, Global Business Units at NuVasive.

Don't Miss

INTERCEPT Blood System for Cryoprecipitation Receives FDA Approval States Cerus Corporation

The system is used to produce Pathogen Reduced Cryoprecipitated Fibrinogen Complex for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. 

Genetron Health Provides Update on HCCscreen™ for Liver Cancer Early Screening in China

Establishes joint venture with Wuxi municipal government; Expects the commercialization and revenues of HCCscreen to accelerate in China.

Research Paper Showing ProtoKinetix AAGP® Enhanced Stem Cell Derived Retina Precursor Cells Restoration of Vision

ProtoKinetix notes the research paper has been submitted to a prestigious journal specializing in tissue regeneration for peer review and editing.

OrganaBio to Expand Its cGMP Cell and Gene Therapy Manufacturing Facility: 19,000 Sq. Ft. Slated to Commence Operations In Q3 2021

OrganBio, a Miami-based cGMP facility, will include process development space, ISO 7 cleanrooms, state-of-the-art scientific equipment, analytics and QC laboratories, and a suite of support services to enable OrganaBio and its partners to rapidly and economically self-manufacture clinical materials. 

Stoke Therapeutics Announces Proposed Public Offering

November 18, 2020 Stoke Therapeutics, Inc., a biotechnology company pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein...